The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
Abstract
BACKGROUND Lobectomy is the standard of care for early-stage non-small-cell lung cancer (NSCLC). The survival and clinical benefits of segmentectomy have not been investigated in a randomised trial setting. We aimed to investigate if segmentectomy was non-inferior to lobectomy in patients with small-sized peripheral NSCLC. METHODS We conducted this randomised, controlled, non-inferiority trial at 70 institutions in Japan. Patients with clinical stage IA NSCLC (tumour diameter ≤2 cm; consolidation-to-tumour ratio >0·5) were randomly assigned 1:1 to receive either lobectomy or segmentectomy. Randomisation was done via the minimisation method, with balancing for the institution, histological type, sex, age, and thin-section CT findings. Treatment allocation was not concealed from investigators and patients. The primary endpoint was overall survival for all randomly assigned patients. The secondary endpoints were postoperative respiratory function (6 months and 12 months), relapse-free survival, proportion of local relapse, adverse events, proportion of segmentectomy completion, duration of hospital stay, duration of chest tube placement, duration of surgery, amount of blood loss, and the number of automatic surgical staples used. Overall survival was analysed on an intention-to-treat basis with a non-inferiority margin of 1·54 for the upper limit of the 95% CI of the hazard ratio (HR) and estimated using a stratified Cox regression model. This study is registered with UMIN Clinical Trials Registry, UMIN000002317. FINDINGS Between Aug, 10, 2009, and Oct 21, 2014, 1106 patients (intention-to-treat population) were enrolled to receive lobectomy (n=554) or segmentectomy (n=552). Patient baseline clinicopathological factors were well balanced between the groups. In the segmentectomy group, 22 patients were switched to lobectomies and one patient received wide wedge resection. At a median follow-up of 7·3 years (range 0·0-10·9), the 5-year overall survival was 94·3% (92·1-96·0) for segmentectomy and 91·1% for lobectomy (95% CI 88·4-93·2); superiority and non-inferiority in overall survival were confirmed using a stratified Cox regression model (HR 0·663; 95% CI 0·474-0·927; one-sided p<0·0001 for non-inferiority; p=0·0082 for superiority). Improved overall survival was observed consistently across all predefined subgroups in the segmentectomy group. At 1 year follow-up, the significant difference in the reduction of median forced expiratory volume in 1 sec between the two groups was 3·5% (p<0·0001), which did not reach the predefined threshold for clinical significance of 10%. The 5-year relapse-free survival was 88·0% (95% CI 85·0-90·4) for segmentectomy and 87·9% (84·8-90·3) for lobectomy (HR 0·998; 95% CI 0·753-1·323; p=0·9889). The proportions of patients with local relapse were 10·5% for segmentectomy and 5·4% for lobectomy (p=0·0018). 52 (63%) of 83 patients and 27 (47%) of 58 patients died of other diseases after lobectomy and segmentectomy, respectively. No 30-day or 90-day mortality was observed. One or more postoperative complications of grade 2 or worse occurred at similar frequencies in both groups (142 [26%] patients who received lobectomy, 148 [27%] who received segmentectomy). INTERPRETATION To our knowledge, this study was the first phase 3 trial to show the benefits of segmentectomy versus lobectomy in overall survival of patients with small-peripheral NSCLC. The findings suggest that segmentectomy should be the standard surgical procedure for this population of patients. FUNDING National Cancer Center Research and the Ministry of Health, Labour, and Welfare of Japan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer
Ginsberg, R. J., & Rubinstein, L. V. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00537-u · Cited by 3,006
Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study
Okada, M., Koike, T., Higashiyama, M., Yamato, Y., Kodama, K., & Tsubota, N. (2006) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2006.02.063 · Cited by 713
Self-citationNakamura, K., Saji, H., Nakajima, R., Okada, M., Asamura, H., Shibata, T., Nakamura, S., Tada, H., & Tsuboi, M. (2010) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyp156 · Cited by 525
Self-citationComparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial
Suzuki, K., Saji, H., Aokage, K., Watanabe, S.-I., Okada, M., Mizusawa, J., Nakajima, R., Tsuboi, M., Nakamura, S., Nakamura, K., et al. (2019) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.03.090 · Cited by 490
Self-citationA single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer
Suzuki, K., Watanabe, S.-I., Wakabayashi, M., Saji, H., Aokage, K., Moriya, Y., Yoshino, I., Tsuboi, M., Nakamura, S., Nakamura, K., et al. (2022) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.09.146 · Cited by 379
Self-citationAsamura, H., Hishida, T., Suzuki, K., Koike, T., Nakamura, K., Kusumoto, M., Nagai, K., Tada, H., Mitsudomi, T., Tsuboi, M., et al. (2013) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2012.12.047 · Cited by 346
Self-citation
Cited by
Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer
Altorki, N., Wang, X., Kozono, D., Watt, C., Landrenau, R., Wigle, D., Port, J., Jones, D. R., Conti, M., Ashrafi, A. S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2212083 · Cited by 1,106
Rapid On-Site AI-Assisted Grading for Lung Surgery Based on Optical Coherence Tomography
Liu, H.-C., Lin, M.-H., Chang, W.-C., Zeng, R.-C., Wang, Y.-M., & Sun, C.-W. (2023) · Cancers · doi:10.3390/cancers15225388 · Cited by 9
Metadata
- Authors
- Saji, H., Okada, M., Tsuboi, M., Nakajima, R., Suzuki, K., Aokage, K., Aoki, T., Okami, J., Yoshino, I., Ito, H., Okumura, N., Yamaguchi, M., Ikeda, N., Wakabayashi, M., Nakamura, K., Fukuda, H., Nakamura, S., Mitsudomi, T., Watanabe, S.-I., & Asamura, H.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2022-04
- Volume
- 399
- Issue
- 10335
- Pages
- 1607-1617
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W4224235086
- Cited by
- 1,729
- References
- 7
- FWCI
- 201.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. https://app.cochat.ai/papers/10.1016/s0140-6736(21)02333-3
- The paper
- Saji, H., Okada, M., Tsuboi, M., Nakajima, R., Suzuki, K., Aokage, K., Aoki, T., Okami, J., Yoshino, I., Ito, H., Okumura, N., Yamaguchi, M., Ikeda, N., Wakabayashi, M., Nakamura, K., Fukuda, H., Nakamura, S., Mitsudomi, T., Watanabe, S.-I., & Asamura, H. (2022). Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. The Lancet. https://doi.org/10.1016/s0140-6736(21)02333-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.